Clinical Trial Update: TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating talazoparib in combination with avelumab as maintenance therapy for platinum-sensitive urothelial carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Talazoparib (talazoparib)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Urothelial Carcinoma | Phase 2 | Status: RECRUITING